KLF9 and cancer: While KLF9 consistently inhibits oncogenic processes, such as EMT, cancer stemness, and immune evasion, its regulatory networks exhibit tissue-specific complexity, governed by microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and post-translational modifications.